News summary

Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression

Source: Science Daily - Health & Medicine • Published: 27 Sept 2026, 13:53

Summarized by Masters of Longevity from Science Daily - Health & Medicine.

Glucosamine and its potential link to Alzheimer’s progression — a news article summarizing research findings and lab experiments and what they might mean for readers.

Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
Key Takeaways
  • Health-record analysis found glucosamine use associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia.
  • Lab experiments indicate glucosamine exposure can intensify abnormal protein glycosylation processes observed in Alzheimer’s brain tissue.
  • Researchers emphasize that clinical trials are needed to determine whether glucosamine causally accelerates cognitive decline.
Read the full article at Science Daily - Health & Medicine ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.